Crossmark

Reduced Dose Ibrutinib Due to Financial Toxicity in CLL

Crossref DOI link: https://doi.org/10.1007/s12288-018-1011-4

Published Online: 2018-09-08

Published Print: 2019-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lad, Deepesh P.

Malhotra, Pankaj

Khadwal, Alka

Prakash, Gaurav

Jain, Arihant

Varma, Subhash
License Information

Text and Data Mining valid from 2018-09-08
More Information

Article History

Received: 17 July 2018

Accepted: 31 August 2018

First Online: 8 September 2018

Compliance with Ethical Standards

:

: The authors report no conflict of interest.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional ethics committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: Informed consent was obtained from all individual participants included in the study.